NYSE: ANIP - ANI Pharmaceuticals

Rentabilité sur six mois: -16.66%
Secteur: Healthcare

Calendrier des promotions ANI Pharmaceuticals

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

ANI Pharmaceuticals, Inc., специализированная фармацевтическая компания, разрабатывает, производит и продает фирменные и генерические рецептурные лекарственные препараты в США и Канаде. Он специализируется на производстве контролируемых веществ, онкологических препаратов, гормонов, стероидов и других препаратов. Компания производит твердые дозированные препараты для перорального применения; полутвердые, жидкие и местные средства; и сильнодействующих продуктов, а также выполняет контрактное производство для других фармацевтических компаний.

plus de détails
Он продает свою продукцию через розничные аптечные сети, оптовых торговцев, дистрибьюторов и аптеки по почте, а также через организации групповых закупок. Компания была основана в 2001 году, ее штаб-квартира находится в Бодетте, штат Миннесота.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2000-05-05
ISIN US00182C1036
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.anipharmaceuticals.com
Changement de prix par jour: -2.74% (55.04)
Changement de prix par semaine: -1.96% (54.6)
Changement de prix par mois: -5.36% (56.56)
Changement de prix sur 3 mois: -8.5% (58.5)
Changement de prix sur six mois: -16.66% (64.23)
Changement de prix par an: -5.66% (56.74)
Evolution du prix sur 3 ans: +27.6% (41.95)
Evolution du prix sur 5 ans: -12.63% (61.27)
Evolution des prix sur 10 ans: 0% (53.53)
Evolution des prix depuis le début de l'année: -1.25% (54.21)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2 7
P/BV 2.25 7
P/E 51.77 3
EV/EBITDA 9.75 8
Total: 7.63

Efficacité

Nom Signification Grade
ROA, % 2.08 1
ROE, % 4.34 1
Total: 2.33

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0.1029

Devoir

Nom Signification Grade
Debt/EBITDA 2.61 5
Total: 4.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 135.69 10
Rentabilité Ebitda, % 75.52 8
Rentabilité EPS, % 103.92 10
Total: 9.6
Plus de détails

Date de transaction Date de divulgation Insider Taper Prix Volume Quantité Partagez jusqu'à, % Partager après, % Document
17.07.2024 17.07.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 63.16 900 472 14257 0 -0.09 lien
16.07.2024 17.07.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 64.27 1 413 940 22000 0 -0.13 lien
15.07.2024 17.07.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 63.38 697 180 11000 0 -0.07 lien
21.06.2024 24.06.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 58.9 1 178 000 20000 0 -0.12 lien
19.04.2024 22.04.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 65.17 1 095 440 16809 0 -0.1 lien
18.04.2024 22.04.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 64.98 677 287 10423 0 -0.06 lien
12.04.2024 15.04.2024 Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.		 Vente 67.79 16 948 250 0 0 lien
13.02.2024 13.02.2024 Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.		 Vente 56.04 14 010 250 0 0 lien
18.01.2024 18.01.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 55.3 541 055 9784 0 -0.06 lien
17.01.2024 18.01.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 55.11 551 100 10000 0 -0.06 lien
16.01.2024 18.01.2024 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 55.63 278 150 5000 0 -0.03 lien
12.01.2024 16.01.2024 Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.		 Vente 56.43 14 108 250 0 0 lien
15.08.2023 16.08.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 61.6 1 361 980 22110 0 -0.13 lien
14.08.2023 16.08.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 61.15 1 705 470 27890 0 -0.17 lien
21.07.2023 21.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 52.56 604 440 11500 0 -0.07 lien
20.07.2023 21.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.52 309 120 6000 0 -0.04 lien
19.07.2023 21.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.48 307 284 5969 0 -0.04 lien
18.07.2023 18.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.84 347 328 6700 0 -0.04 lien
17.07.2023 18.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.06 501 971 9831 0 -0.06 lien
14.07.2023 18.07.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 50.43 504 300 10000 0 -0.06 lien
22.06.2023 23.06.2023 Gassert Chad
SVP - CORP. DEV. & STRATEGY		 Vente 51.32 1 026 400 20000 0 -0.12 lien
22.06.2023 22.06.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.38 693 630 13500 0 -0.08 lien
21.06.2023 22.06.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.95 615 244 11843 0 -0.07 lien
20.06.2023 22.06.2023 Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS		 Vente 51.93 761 138 14657 0 -0.09 lien

Établissements Volume Partager, %
Blackrock Inc. 2524893 12.03
Vanguard Group Inc 1288972 6.14
Rubric Capital Management LP 1125000 5.36
Deep Track Capital, LP 600000 2.86
State Street Corporation 592423 2.82
Dimensional Fund Advisors LP 591731 2.82
Global Alpha Capital Management Ltd. 582428 2.78
William Blair Investment Management, LLC 490557 2.34
Ranger Investment Management, L.p. 434617 2.07
Geode Capital Management, LLC 329689 1.57

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
Invesco Pharmaceuticals ETF 3.07684 7.16 1.74279
SPDR S&P Pharmaceuticals ETF 1.59797 29.8 1.29889
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 0.90096 86.72 1.2989
Invesco Dorsey Wright Healthcare Momentum ETF 0.7385 1.46 0.12263
Invesco S&P SmallCap Health Care ETF 0.65584 5.21 0.41696
Invesco S&P SmallCap 600® Pure Growth ETF 0.6438 32.37 1.34638
ETC 6 Meridian Low Beta Equity ETF 0.40673 22.48 2.13049
First Trust Active Factor Small Cap ETF 0.39074 34.25 1.61948
iShares U.S. Pharmaceuticals ETF 0.38263 1.88 1.97922
Invesco Dorsey Wright SmallCap Momentum ETF 0.32706 33.91 0.61241
First Trust Small Cap Growth AlphaDEX Fund 0.31229 42.5 1.22182
Royce Quant Small‑Cap Quality Value ETF 0.26594 21.83 1.62596
Syntax Stratified SmallCap ETF 0.26315 13.51 1.639
JPMorgan Diversified Return U.S. Small Cap Equity ETF 0.18689 26.04 2.20258
Invesco S&P SmallCap Momentum ETF 0.17803 42.6 1.30511
Vanguard S&P Small-Cap 600 Growth ETF 0.16 30.31 1.37064
VictoryShares US Small Cap Volatility Wtd ETF 0.14765 30.08 1.67818
VictoryShares US Discovery Enhanced Volatility Wtd ETF 0.14291 21.4 1.67826
SPDR S&P 600 Small Cap Growth ETF 0.13982 12.28 1.33495
Future Tech ETF 0.12209 426.34 0.8416
Principal Healthcare Innovators ETF 0.12209 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.12201 28.58 0.8565
WisdomTree U.S. SmallCap Fund 0.11836 10.76 1.80258
Avantis U.S Small Cap Equity ETF 0.1117 27.77 1.68271
First Trust Small Cap Core AlphaDEX Fund 0.10833 12.85 1.87983
Principal U.S. Small-Cap ETF 0.09974 14.66 1.20466
Fidelity Small-Mid Multifactor ETF 0.09552 32.31 1.59943
Vanguard U.S. Momentum Factor ETF 0.09 27.18 1.05834
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.08615 16.5 1.66828
ProShares Ultra Nasdaq Biotechnology 0.08498 51.7 0.85651
Invesco Russell 2000 Dynamic Multifactor ETF 0.08344 6.38 1.64004
Vanguard U.S. Quality Factor ETF 0.08 13.91 1.62247
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.07859 31.36 1.41955
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.07137 24.75 1.59225
SPDR Portfolio S&P 600 Small Cap ETF 0.07006 10.23 1.84119
Vanguard S&P Small-Cap 600 ETF 0.07 9.86 1.89226
First Trust Multi Cap Growth AlphaDEX Fund 0.06623 41.56 1.02425
Vanguard Russell 2000 Growth ETF 0.06 17.39 0.60264
iShares Russell 2000 Growth ETF 0.05742 38.04 0.6026
ProShares Ultra SmallCap600 0.05087 49.8 1.83727
Vanguard U.S. Multifactor ETF 0.05 15.57 2.39666
iShares Morningstar Small-Cap Growth ETF 0.04555 590.83 0.72598
iShares Morningstar Small-Cap Growth ETF 0.04555 33.63 0.72598
Vanguard Russell 2000 ETF 0.04 14.37 1.48801
SPDR SSGA US Small Cap Low Volatility Index ETF 0.03927 34.33 2.97092
Invesco S&P SmallCap 600 Revenue ETF 0.03193 30.92 1.94562
ProShares UltraPro Russell2000 0.02385 89.82 1.47873
Avantis U.S. Small Cap Value ETF 0.0237 29.3 2.3212
Dimensional U.S. Targeted Value ETF 0.02368 26.01 1.93487
iShares Morningstar Small-Cap ETF 0.02332 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.02332 391.25 1.60498
Schwab U.S. Small-Cap ETF 0.02298 13.35 1.51433
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01989 15.15 1.75869
Fidelity MSCI Health Care Index ETF 0.01462 0.1657 1.46057
Hartford Longevity Economy ETF 0.00916 25.01 1.53371
Dimensional US Marketwide Value ETF 0.00912 24.88 2.11042
Humankind US Stock ETF 0.00899 18.81 1.99919
Dimensional U.S. Core Equity 2 ETF 0.00812 30.76 1.47098
ProShares Hedge Replication ETF 0.00691 5.92 1.47892
Dimensional U.S. Equity ETF 0.00401 31.53 1.3557
SPDR S&P 1500 Momentum Tilt ETF 0.0038 38.25 1.12176
Avantis U.S. Equity ETF 0.00375 20.45 1.59151
Dimensional US Core Equity Market ETF 0.00315 30.98 1.40618
iShares Russell 3000 ETF 0.00216 23.61 1.43482
Schwab U.S. Broad Market ETF 0.00156 23.7 1.43354
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.0006 23.31 1.46083
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00057 20.03 1.69572
Vanguard Russell 3000 ETF 0 31.87 1.43817



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Nikhil Lalwani President, CEO & Director 1.31M 1978 (47 années)
Mr. Stephen P. Carey Senior VP of Finance & CFO 751k 1971 (54 année)
Mr. James G. Marken Senior Vice President of Operations 673.23k 1963 (62 année)
Mr. Christopher K. Mutz Senior Vp & Head of Rare Disease 565.17k 1972 (53 année)
Mr. Ori Gutwerg Senior Vice President of Generics 623.89k 1975 (50 années)
Mr. Chad Gassert Senior Vice President of Corporate Development & Strategy N/A 1976 (49 années)
Mr. Muthusamy Shanmugam MS R.Ph. Head of R&D, COO of Novitium Operations & Director N/A 1968 (57 années)
Ms. Elizabeth Powell J.D. Chief Compliance Officer & Head of Legal of Rare Disease N/A
Ms. Meredith W. Cook Senior VP, General Counsel & Corporate Secretary N/A 1975 (50 années)
Ms. Krista L. Davis Senior VP & Chief Human Resources Officer N/A 1974 (51 année)

Adresse: United States, Baudette, MN , 210 Main Street West - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://www.anipharmaceuticals.com